Elizabeth Evans, MD, and Deslyn Hobson, MD, highlight how non-estrogen therapies such as ospemifene can effectively manage symptoms

Despite widespread awareness of guidelines, many health care providers fall short in consistently screening and referring postpartum women for depression, putting maternal mental health at risk.

Jill Liss, MD, shares details on her presentation on the physiology of menopause care and how clinicians can use evidence to improve patient care at the 2025 ACOG ACSM.

Elizabeth Mollard, PhD, WHNP, CNM, shares her research, presented at the 2025 ACOG ACSM, on Medicaid postpartum depression (PPD) screening and coverage policies on PPD diagnosis.

Victoria Wang, MD, discusses updated ASCCP recommendations for post-treatment monitoring of high-grade dysplasia and the importance of identifying high-risk patients early.

Farah Amro, MD, shares her research at the 2025 ACOG ACSM on leaving the placenta in situ in select patients with placenta accreta spectrum.

Laurence Shields, MD, shares details from his latest study on hemorrhage control devices for postpartum hemorrhage at the 2025 ACOG ACSM.

A new study presented at the 2025 ACOG Annual Clinical & Scientific Meeting found that while recurrent uterine rupture is rare, patients with a history of rupture face a significantly increased subsequent risk of preterm delivery.

A recent study presented at the 2025 ACOG Annual Clinical and Scientific Meeting found that most TikTok videos on hormonal contraception was misleading.

A new study presented at the 2025 ACOG Annual Clinical & Scientific Meeting reveals that a self-screening survey with educational videos enables most patients to determine medication abortion eligibility without an ultrasound.

A new study presented at 2025 ACOG Annual Clinical and Scientific Meeting found disparities between RSV uptake in pregnant patients.

Postpartum depression often goes undiagnosed because of a lack of screening and stigma—learn how early detection, open conversations, and new treatment options can improve outcomes for mothers.

In this Q&A, experts explain how ACOG’s tailored prenatal care model supports flexibility, equity, and shared decision-making in pregnancy.

Azithromycin and doxycycline carry a greater risk of vulvovaginal candidiasis compared to other acne treatments, researchers report at ACOG ACSM 2025.

A meta-analysis presented at 2025 ACOG Annual Clinical & Scientific Meeting found that elinzanetant demonstrated a reduction in VMS frequency and intensity.

Shared decision making and individualized strategies are emphasized in the new ACOG consensus.

A new study presented at the 2025 ACOG Annual Clinical & Scientific Meeting reveals that physiotherapy support during labor lowers the chances of cesarean delivery, severe perineal tears, and labor pain.

New research presented at the 2025 ACOG Annual Clinical & Scientific Meeting reveals that mandatory in-person consent and waiting periods in Ohio create significant delays and barriers to abortion access.

A quick look into some of the top sessions occurring at the 2025 ACOG Annual Clinical and Scientific Meeting, being held from May 16-18, 2025, in Minneapolis, Minnesota.